Dawn E. Quelle

7.9k total citations · 3 hit papers
70 papers, 6.5k citations indexed

About

Dawn E. Quelle is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, Dawn E. Quelle has authored 70 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 33 papers in Molecular Biology and 22 papers in Neurology. Recurrent topics in Dawn E. Quelle's work include Cancer-related Molecular Pathways (30 papers), Neuroblastoma Research and Treatments (16 papers) and Neurofibromatosis and Schwannoma Cases (14 papers). Dawn E. Quelle is often cited by papers focused on Cancer-related Molecular Pathways (30 papers), Neuroblastoma Research and Treatments (16 papers) and Neurofibromatosis and Schwannoma Cases (14 papers). Dawn E. Quelle collaborates with scholars based in United States, United Kingdom and France. Dawn E. Quelle's co-authors include Charles J. Sherr, Martine F. Roussel, Jun‐ya Kato, Richard A. Ashmun, Sheila Shurtleff, Frédérique Zindy, H Matsushime, Masatoshi Shibuya, Takehiko Kamijo and Gerard C. Grosveld and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Dawn E. Quelle

68 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19

1997 1.3k citations Dawn E. Quelle, Charles J. Sherr et al. profile →
D-type cyclin-dependent kinase activity in mammalian cells.

1994 965 citations Dawn E. Quelle, Sheila Shurtleff et al. Molecular and Cellular Biology profile →
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

1993 947 citations Dawn E. Quelle, Sheila Shurtleff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn E. Quelle United States	30	4.5k	3.7k	896	725	600	70	6.5k
Takehiko Kamijo Japan	37	5.1k 1.1×	3.2k 0.8×	574 0.6×	1.0k 1.4×	805 1.3×	114	7.1k
Earlene M. Schmitt United States	10	5.0k 1.1×	4.0k 1.1×	691 0.8×	1.1k 1.5×	315 0.5×	13	7.5k
Ada Sacchi Italy	55	5.8k 1.3×	3.7k 1.0×	1.2k 1.4×	1.5k 2.1×	550 0.9×	162	8.4k
Richard A. Ashmun United States	30	5.9k 1.3×	4.5k 1.2×	1.0k 1.2×	917 1.3×	493 0.8×	53	8.4k
Martin van der Valk Netherlands	33	4.0k 0.9×	3.6k 1.0×	570 0.6×	703 1.0×	200 0.3×	45	6.9k
Carla Grandori United States	30	5.1k 1.2×	1.7k 0.4×	551 0.6×	1.1k 1.5×	765 1.3×	63	6.4k
Christine M. Eischen United States	44	5.0k 1.1×	3.1k 0.8×	462 0.5×	1.5k 2.0×	322 0.5×	99	6.8k
David O. Ferguson United States	40	6.2k 1.4×	2.4k 0.7×	572 0.6×	1.4k 1.9×	532 0.9×	67	7.6k
C J Sherr United States	18	4.3k 1.0×	3.9k 1.0×	986 1.1×	687 0.9×	173 0.3×	19	6.0k
Rachel A. Ridgway United Kingdom	29	3.5k 0.8×	2.5k 0.7×	825 0.9×	1.2k 1.6×	207 0.3×	45	6.3k

Countries citing papers authored by Dawn E. Quelle

Since Specialization

Citations

This map shows the geographic impact of Dawn E. Quelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Quelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Quelle more than expected).

Fields of papers citing papers by Dawn E. Quelle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn E. Quelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Quelle. The network helps show where Dawn E. Quelle may publish in the future.

Co-authorship network of co-authors of Dawn E. Quelle

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn E. Quelle. A scholar is included among the top collaborators of Dawn E. Quelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn E. Quelle. Dawn E. Quelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koppenhafer, Stacia L., et al.. (2025). Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells. Cancer Research Communications. 5(6). 1034–1048.

Swier, Vicki J., Katherine A. White, Tyler B. Johnson, et al.. (2024). NF1^+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1‐associated cognitive and motor impairment. Clinical and Translational Science. 17(6). e13858–e13858. 3 indexed citations

Xiao, S., Irena Gribovskaja‐Rupp, Dawn E. Quelle, et al.. (2024). GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors. Surgery. 179. 108943–108943. 9 indexed citations

Quelle, Dawn E., et al.. (2023). FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy. International Journal of Molecular Sciences. 24(17). 13596–13596. 5 indexed citations

Leidinger, Mariah, Stacia L. Koppenhafer, David J. Gordon, et al.. (2022). Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo. Neuro-Oncology Advances. 4(1). vdac047–vdac047. 5 indexed citations

Gutierrez, Wade R., Vickie Knepper-Adrian, Dawn E. Quelle, et al.. (2022). Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism. JCI Insight. 7(22). 7 indexed citations

Kumar, Suresh, Po Hien Ear, Kate E Lines, et al.. (2022). Preclinical Models of Neuroendocrine Neoplasia. Cancers. 14(22). 5646–5646. 6 indexed citations

Pulliam, Casey, Vickie Knepper-Adrian, Rajesh Khanna, et al.. (2020). RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors. Clinical Cancer Research. 26(12). 2997–3011. 40 indexed citations

Scott, Aaron T., Patrick Breheny, Po Hien Ear, et al.. (2020). Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Clinical Cancer Research. 26(8). 2011–2021. 40 indexed citations

10.

Gourronc, Françoise A., Kathleen R. Markan, Katarina Kulhánková, et al.. (2020). Pdgfrα-Cre mediated knockout of the aryl hydrocarbon receptor protects mice from high-fat diet induced obesity and hepatic steatosis. PLoS ONE. 15(7). e0236741–e0236741. 14 indexed citations

11.

Hagen, Jussara, Sara M. Reed, Agshin F. Taghiyev, et al.. (2014). RABL6A Promotes G1–S Phase Progression and Pancreatic Neuroendocrine Tumor Cell Proliferation in an Rb1-Dependent Manner. Cancer Research. 74(22). 6661–6670. 28 indexed citations

12.

Sieren, Jessica C., David K. Meyerholz, Xiaojun Wang, et al.. (2014). Development and translational imaging of a TP53 porcine tumorigenesis model. Journal of Clinical Investigation. 124(9). 4052–4066. 73 indexed citations

13.

Barnes, J. Matthew, Seema Paliwal, Xuefeng Zhang, et al.. (2011). The ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of p53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma Metastasis. Molecular Cancer Research. 9(7). 867–877. 24 indexed citations

14.

Hagen, Jussara, Van S. Tompkins, Amel Dudakovic, Jamie A. Weydert, & Dawn E. Quelle. (2008). Generation and Characterization of Monoclonal Antibodies to NIAM: A Nuclear Interactor of ARF and Mdm2. Hybridoma. 27(3). 159–166. 4 indexed citations

15.

Groskreutz, Dayna J., Martha M. Monick, Timur O. Yarovinsky, et al.. (2007). Respiratory Syncytial Virus Decreases p53 Protein to Prolong Survival of Airway Epithelial Cells. The Journal of Immunology. 179(5). 2741–2747. 65 indexed citations

16.

Miller, Shyra J., Fatima Rangwala, Jon Williams, et al.. (2006). Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues. Cancer Research. 66(5). 2584–2591. 158 indexed citations

17.

Korgaonkar, Chandrashekhar K., Jussara Hagen, Van S. Tompkins, et al.. (2005). Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function. Molecular and Cellular Biology. 25(4). 1258–1271. 242 indexed citations

18.

Korgaonkar, Chandrashekhar K., et al.. (2002). ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization. Molecular and Cellular Biology. 22(1). 196–206. 99 indexed citations

19.

Matsushime, Hitoshi, Dawn E. Quelle, Sheila Shurtleff, et al.. (1994). D-Type Cyclin-Dependent Kinase Activity in Mammalian Cells. Molecular and Cellular Biology. 14(3). 2066–2076. 305 indexed citations

20.

Quelle, Dawn E., Frederick W. Quelle, & Don M. Wojchowski. (1992). Mutations in the WSAWSE and Cytosolic Domains of the Erythropoietin Receptor Affect Signal Transduction and Ligand Binding and Internalization. Molecular and Cellular Biology. 12(10). 4553–4561. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact